Quimiging, Lenie .
HRN: 11-72-37 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 1.5GM (VIAL)
09/24/2025
09/30/2025
IV
1.5 G
Q8H
UTI
Checking Initial Appropriateness
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/02/2025
IV
500mg
Q8h
Amoebiasis
Checking Initial Appropriateness